← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-6 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

Retinitis Pigmentosa; Retinitis · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
ADCBiologicstaleGruppo Italiano Malattie EMatol…Phase 3

Gilteritinib Fumarate (Gilteritinib Fumarate)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
ADCBiologicstaleHarpoon Therapeutics, Inc., a s…Phase 2

Gocatamig (Gocatamig)

Small-Cell Lung Cancer; Neuroendocrine Carcinoma · Small-Cell Lung Cancer

#Small-CellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

H1: TROP2 ADC (H1: TROP2 ADC)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleShanghai JMT-Bio Inc.Phase 3

HB1801 (HB1801)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE2 + HLX10 (HLX43 DOSE2 + HLX10)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

Refractory and Relapsed T Cell Lymphoma · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

IDOV-SAFE (IDOV-SAFE)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
ADCBiologicstaleGilead SciencesPhase 2

IMMU 130 (IMMU 130)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 DISCONTINUED
ADCBiologicstaleSeagenPreclinical

Brentuximab vedotin plus Chidamide (Induction therapy-3 cycles of BvC, Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
CGTBiologicstaleJuno Therapeutics, a Subsidiary…Preclinical

JCAR015 (JCAR015)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTBiologicstalePeter MacCallum Cancer Centre, …Phase 1

LeY CAR T cells (LeY CAR T cells)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
AntibodystaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#항체#면역항체+3
임상시험 3상태 DISCONTINUED
ADCBiologicstaleNational Center for Complementa…Phase 2

MAD CP (MAD CP)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 3상태 RECRUITING
AntibodystaleRochePhase 1

trastuzumab (Herceptin, MM-111 + Herceptin)

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Phase1#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleRochePhase 2

rituximab (MabThera®, MabThera® (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 3상태 DISCONTINUED
CGTBiologicstaleStephan Grupp MD PhDPhase 2

Murine CART19 (Murine CART19)

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL · Pediatric and Young Adult Patientswith H

#PediatricandYoungAdultPatientswi#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 3상태 RECRUITING
CGTBiologicstaleNkarta, Inc.Phase 1

NKG2D CAR-NK (NKG2D CAR-NK)

AML · AML

#AML#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE

57 / 177 페이지

← 이전다음 →